Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. Methods: We enrolled 194 RA patients and 1002 healthcare workers (HCWs) as controls. Clinical, lifes...

Descripción completa

Detalles Bibliográficos
Autores principales: Picchianti-Diamanti, Andrea, Navarra, Assunta, Aiello, Alessandra, Laganà, Bruno, Cuzzi, Gilda, Salmi, Andrea, Vanini, Valentina, Maggi, Fabrizio, Meschi, Silvia, Matusali, Giulia, Notari, Stefania, Agrati, Chiara, Salemi, Simonetta, Di Rosa, Roberta, Passarini, Damiano, Di Gioia, Valeria, Sesti, Giorgio, Conti, Fabrizio, Spinelli, Francesca Romana, Corpolongo, Angela, Chimenti, Maria Sole, Ferraioli, Mario, Sebastiani, Gian Domenico, Benucci, Maurizio, Li Gobbi, Francesca, Santoro, Anna Paola, Capri, Andrea, Puro, Vincenzo, Nicastri, Emanuele, Goletti, Delia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675674/
https://www.ncbi.nlm.nih.gov/pubmed/38006015
http://dx.doi.org/10.3390/vaccines11111684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675674/
https://www.ncbi.nlm.nih.gov/pubmed/38006015
http://dx.doi.org/10.3390/vaccines11111684

Ejemplares similares